221
Participants
Start Date
December 8, 2017
Primary Completion Date
August 30, 2021
Study Completion Date
August 30, 2021
DSP-7888 Dosing Emulsion
DSP-7888 Dosing Emulsion will be administered i.d. every 7 ± 1 day for Doses 1 to 5, every 14 ± 3 days for Doses 6 to 15, and every 28 ± 7 days for Doses 16 and above.
Bevacizumab
Bevacizumab will be administered intravenously every 14 ± 3 days at 10 mg/kg.
National Taiwan University Hospital, Taipei
Weill Cornell Medicine, New York
Columbia University Medical Center/ Neurological Institute of NY, New York
Seoul National University Bundang Hospital, Seongnam-si
Dent Neurosciences Research Center, Amherst
University of Rochester Medical Center, Rochester
University of Pittsburgh Medical Center (UPMC), Pittsburgh
Hospital of the University of Pennsylvania, Philadelphia
Virginia Cancer Specialists, PC, Fairfax
Piedmont brain tumor center, Atlanta
University of Alabama at Birmingham, Birmingham
University of Tennessee Academic Medical Center Cancer Institute, Knoxville
Norton Cancer Institute, Louisville
China Medical University Hospital, Taichung
University of Kentucky / Department of Internal Medicine / Markey Cancer Center, Lexington
University of Toledo, Toledo
University Hospitals of Cleveland, Cleveland
Cleveland Clinic Taussig Cancer Center, Cleveland
Henry Ford Health System, Detroit
University of Wisconsin Hospital, Madison
Abbott Northwestern Hospital, Minneapolis
Rush University Medical Center, Chicago
Highlands Oncology Group, Fayetteville
Baylor Scott and White, Dallas
Houston Methodist, Houston
Mischer Neuroscience Associates/Memorial Hermann Hospital, Houston
Renovatio Clinical, The Woodlands
Texas Oncology Austin Midtown, Austin
Rocky Mountain Cancer Center, Denver
Center for Neurosciences, Tucson
Kaiser Permanente Los Angeles Medical Center, Los Angeles
Cedars Sinai Medical Center, Los Angeles
John Wayne Cancer Institute, Santa Monica
UCSD- Moores Cancer Center, La Jolla
Neuro-Oncology/ US Irvine Medical Center, Orange
Sansum Clinic, Santa Barbara
Swedish Medical Center, Seattle
Tufts Medical Center, Boston
Hackensack University Medical Center, Hackensack
Rhode Island Hospital, Providence
CancerCare Manitoba, Winnipeg
Montreal Neurological Institute and Hospital, Montreal
University of Sherbrooke, Sherbrooke
Hokkaido University Hospital, Sapporo
Kagoshima University Hospital, Kagoshima
Niigata University Medical and Dental Hospital, Chuo Ku
Osaka International Cancer Institute, Chuo Ku
The University of Tokyo Hospital, Bunkyo-ku
National Cancer Center Hospital, Chuo-ku
Hiroshima University Hospital, Hiroshima
Kumamoto University Hospital, Kumamoto
University Hospital, Kyoto Prefectural University of Medicine, Kyoto
National Hospital Organization Kyoto Medical Center, Kyoto
Tokyo Women's Medical University Hospital, Shinjuku-Ku
Yamagata University Hospital, Yamagata
Seoul National University Hospital, Seoul
Severance Hospital, Seoul
Gangnam Severance Hospital, Seoul
Samsung Medical Center, Seoul
The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul
Chang Gung Memorial Hospital, Taoyuan
Sumitomo Pharma America, Inc.
INDUSTRY